Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic pathology in Western countries. It encompasses a spectrum of conditions ranging from simple steatosis to more severe and progressive non-alcoholic steatohepatitis (NASH) that can lead to hepatocellular carcinoma (H...
Saved in:
Main Authors: | Sophie Jacques, Arash Arjomand, Hélène Perée, Patrick Collins, Alice Mayer, Arnaud Lavergne, Marie Wéry, Myriam Mni, Alexandre Hego, Virginie Thuillier, Guillaume Becker, Mohamed Ali Bahri, Alain Plenevaux, Emmanuel Di Valentin, Cécile Oury, Michel Moutschen, Philippe Delvenne, Nicolas Paquot, Souad Rahmouni |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/10538d19699b48e291e33a6afd964897 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins in Non-alcoholic Steatohepatitis
by: Jose D. Torres-Peña, et al.
Published: (2021) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
by: Takemi Akahane, et al.
Published: (2021) -
Cathepsin D regulates lipid metabolism in murine steatohepatitis
by: Tom Houben, et al.
Published: (2017) -
New approach to determine the healthy immune variations by combining clustering methods
by: Claire Liefferinckx, et al.
Published: (2021) -
Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway.
by: Farah Ketroussi, et al.
Published: (2011)